Corporate, Microbial Genomics

Illumina Statement on Novel Coronavirus

Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities.

Illumina Statement on Novel Coronavirus
March 17, 2020

With the global spread of SARS-CoV-2, Illumina has enacted precautionary measures focusing on the health and safety of our employees, families, customers and communities. To help protect Illumina employees and business continuity, we have proactively implemented efforts including limiting travel and attendance at meetings and conferences, and allowing employees to work remotely, where possible. We are closely monitoring the situation and will update our action plan to protect employees, keep customers running and support efforts to minimize the spread of the virus. To date, we have not experienced sustained supply chain or other operational delays. We will continue to monitor and update as the situation evolves, balancing the safety of our employees and the needs of our customers. 

 

 

Recent Articles

How Comprehensive Genomic Profiling Is Helping Cancer Patients Today
How Comprehensive Genomic Profiling Is Helping Cancer Patients Today
Illumina Grant Boosts Climate Action and Job Training
Illumina Grant Boosts Climate Action and Job Training
Delivering the Future of Diagnostics and Precision Oncology
Delivering the Future of Diagnostics and Precision Oncology